BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32420884)

  • 1. [COVID-19 and cardiovascular diseases: viewpoint for older patients].
    Boureau AS; de Decker L; Berrut G; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2020 Jun; 18(2):141-149. PubMed ID: 32420884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and cardiovascular disease: characteristic features in older patients.
    Boureau AS; de Decker L; Berrut G; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2020 Jun; 18(2):141-148. PubMed ID: 33064080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further developments in the literature on RAAS inhibitors and COVID-19.
    Quinn KL; Fralick M; Zipursky JS; Stall NM
    CMAJ; 2020 Jun; 192(26):E727. PubMed ID: 32601253
    [No Abstract]   [Full Text] [Related]  

  • 4. What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.
    Wong SY; Brubaker AL; Wang AX; Taiwo AA; Melcher ML
    Clin Transplant; 2020 Jul; 34(7):e13991. PubMed ID: 32446267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COVID-19 and the impact of cardiovascular comorbidities].
    Seoudy H; Frey N
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1157-1160. PubMed ID: 32791552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):565-566. PubMed ID: 32842268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.
    Hrenak J; Zorad S; Simko F
    Gen Physiol Biophys; 2020 May; 39(3):203-204. PubMed ID: 32525813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and the heart: An update for clinicians.
    Goha A; Mezue K; Edwards P; Nunura F; Baugh D; Madu E
    Clin Cardiol; 2020 Nov; 43(11):1216-1222. PubMed ID: 32533585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and the Cardiovascular System.
    Veer M; Kumar AM; Ivanova V
    Crit Care Nurs Q; 2020; 43(4):381-389. PubMed ID: 32833774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and cardiovascular diseases.
    Mai F; Del Pinto R; Ferri C
    J Cardiol; 2020 Nov; 76(5):453-458. PubMed ID: 32736906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.
    Samidurai A; Das A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
    Tadic M; Cuspidi C; Mancia G; Dell'Oro R; Grassi G
    Pharmacol Res; 2020 Aug; 158():104906. PubMed ID: 32461198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

  • 14. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.
    Cappuccio FP; Siani A
    Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1227-1235. PubMed ID: 32595085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
    Hendren NS; Drazner MH; Bozkurt B; Cooper LT
    Circulation; 2020 Jun; 141(23):1903-1914. PubMed ID: 32297796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.
    Vázquez-Cornejo E
    Bol Med Hosp Infant Mex; 2020; 77(5):274-281. PubMed ID: 33064690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the work mode of cardiologists during the COVID-19 epidemic in Wuhan.
    Cheng X; Ma C; Han Y
    Eur Heart J; 2020 Aug; 41(29):2729-2730. PubMed ID: 32406507
    [No Abstract]   [Full Text] [Related]  

  • 18. Telemedicine in cardiology in the time of coronavirus disease 2019: a friend that everybody needs.
    Koulaouzidis G; Charisopoulou D; Wojakowski W; Koulaouzidis A; Marlicz W; Jadczyk T
    Pol Arch Intern Med; 2020 Jun; 130(6):559-561. PubMed ID: 32539313
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characteristics of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) patients in Hospital Tengku Ampuan Afzan.
    Soh TV; Dzawani M; Noorlina N; Nik F; Norazmi A
    Med J Malaysia; 2020 Sep; 75(5):479-484. PubMed ID: 32918413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
    Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD
    J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.